NASDAQ: ANIP
ANI Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
After hours: $75.80(+0.6%) · as of 7:39 PM ET
Market Cap
$1.71B
52w High
$99.50
52w Low
$70.15
P/E
15.60
Volume
318.22K
Outstanding Shares
22.73M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 17.32% over the last year. Revenue grew 30.9% over the trailing twelve months. Operating margin moved from 2.03% to 15.35%. Free cash flow grew 51.72% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 11th percentile of their historical P/FCF range. That looks more like a rerating of the multiple than a collapse in the business.
What would invalidate this read
This read changes if operating margin (currently 15.35%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
Valuation
Stock splits
Every 6 shares became 1
Every 6 shares became 1
Every 10 shares became 1
Profitability & growth
Analyst consensus
6
Buy
4
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 6, 2026
Q4 FY26 · EPS est $2.20 · Revenue est $280.06M
View